Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: NANOCOMPOSIX, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-06-17 to 2022-04-16
Current total value of award: $600000
Description: EO14042 THE OBJECTIVE OF THIS CONTRACT IS TO GENERATE AN EFFECTIVE HIV VACCINE USING THE TARGETED AND CONTROLLED DELIVERY OF ANTIGENS TO ANTIGEN PRESENTING CELLS (APC). ENGINEERED NANOPARTICLES LOADED WITH MRNA CAPTURED BEHIND PH SENSITIVE POLYMER.